uracil has been researched along with Arteriosclerosis, Coronary in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nabavizadeh, P | 1 |
| Steen, DL | 1 |
| Kato, S | 1 |
| Fukui, K | 1 |
| Kirigaya, H | 1 |
| Gyotoku, D | 1 |
| Iinuma, N | 1 |
| Kusakawa, Y | 1 |
| Iguchi, K | 1 |
| Nakachi, T | 1 |
| Iwasawa, T | 1 |
| Kimura, K | 1 |
1 trial available for uracil and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipepti | 2016 |
1 other study available for uracil and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Highlights from the European society of cardiology congress 2020.
Topics: Atrial Fibrillation; Benzhydryl Compounds; Benzylamines; Cardiomyopathy, Hypertrophic; Cardiovascula | 2021 |